Observational studyJournal of cancer research and clinical oncology2024

Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center Kiel.

Carolin Grote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.